trending Market Intelligence /marketintelligence/en/news-insights/trending/U-ugGCfnXLdT1_1bOnTEIw2 content esgSubNav
In This List

ContraVir Pharmaceuticals chief medical officer steps down

Blog

Baird Research is Now Exclusively Available in S&P Global’s Aftermarket Research Collection

Blog

Japan M&A By the Numbers: Q4 2023

Blog

Essential IR Insights Newsletter Fall - 2023

Case Study

A Corporation Clearly Pinpoints Activist Investor Activity


ContraVir Pharmaceuticals chief medical officer steps down

ContraVir Pharmaceuticals Inc. said John Sullivan-Bolyai is stepping down as chief medical officer and taking on a new role in the company, effective Dec. 29.

Sullivan-Bolyai will serve as a part-time consultant to the company, where he will remain involved in strategic decisions as well as medical and clinical affairs.